Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus

• Status: Completed
• Trial end date: 2017-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this prospective randomized and double blind controlled study is to evaluate the efficacy and safety of Sulodexide (25 mg) in the treatment of chronic idiopathic subjective tinnitus.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: St Joseph University, Beirut, Lebanon
• Treatments: Glucuronyl glucosamine glycan sulfate

Criteria

Inclusion Criteria:

• Tinnitus for minimum of 1 year

• Absence of psychiatric or neurological diseases

• Absence of any disease that explains tinnitus

• Noise-induced hearing loss

• Cochlear and retro-cochlear damage

Exclusion Criteria:

• Conductive hearing loss

• Mixed hearing loss

• Meniere's disease

• Systemic vascular disease

• Diabetic disease

• Vestibular schwannoma

• Cerebello-pontine angle tumors

• Pulsatile tinnitus

• Pregnancy